Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in Kenya
Kenya: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 81.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Kenya, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine second-dose (mcv2) immunization coverage in Kenya stood at 81.0%. That is the highest value across all 26 years on record.
Compared with earlier readings it is up 6.6% on the previous year and up 189.3% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Kenya peaked at 81.0% in 2025 and was at its lowest, 0.0%, in 2000.
That places Kenya 106th out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Kenya, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 28.0% | — |
| 2016 | 35.0% | +25.0% |
| 2017 | 41.0% | +17.1% |
| 2018 | 53.0% | +29.3% |
| 2019 | 60.0% | +13.2% |
| 2020 | 67.0% | +11.7% |
| 2021 | 71.0% | +6.0% |
| 2022 | 70.0% | -1.4% |
| 2023 | 76.0% | +8.6% |
| 2024 | 76.0% | +0.0% |
| 2025 | 81.0% | +6.6% |
Kenya compared with similar countries
- Kenya's 81.0% is above the median for lower middle income countries, which is 70.0%, 1.2× the median. (47 countries reporting)
- Kenya's 81.0% is above the median for Sub-Saharan Africa, which is 66.0%, 1.2× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 21.7% | 0.0% | 60.0% | 10 |
| 2020s | 73.5% | 67.0% | 81.0% | 6 |
Countries ranked near Kenya
More health data for Kenya
- Un projection of annual infant deaths, annual growth rate -1.44 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6026 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,119 deaths per 1,000 people (2090)
- Number of infants who die before age 1 16,059 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 89 (2025)
- Population ages 00-04, female, annual growth rate 1.28 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0621 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.28 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Kenya?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Kenya was 81.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Kenya?
- The highest recorded value was 81.0% in 2025.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Kenya?
- The lowest recorded value was 0.0% in 2000.
- How does Kenya rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Kenya ranks 106th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Kenya?
- Over the last ten years it is up 189.3%. The long-run trend across the full record is volatile.
- Where does this Kenya data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).